Premium
Use of Plasma Exchange and Heparin During Cardiopulmonary Bypass for a Patient with Heparin Induced Thrombocytopenia: A Case Report
Author(s) -
Kajitani Michio,
Aguinaga Miguel,
Johnson Charles E.,
Scott Margie A.,
Antakli Tamim
Publication year - 2001
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.1540-8191.2001.tb00527.x
Subject(s) - medicine , heparin induced thrombocytopenia , cardiopulmonary bypass , heparin , platelet factor 4 , platelet , anesthesia , cardiology , intensive care medicine
A bstract Patients with documented history of heparin‐induced thrombocytopenia (HIT) pose a difficult problem during surgery using cardiopulmonary bypass (CPB). Several alternative to heparin exist, but these products either are not approved for use in the United States or have more side effects than heparin. We report on a patient with documented heporin‐induced antibody and left main coronary artery disease who underwent uneventful coronary artery bypass surgery and recovery by using preoperative plasmaphresis and limited use of porcine intestinal heparin during CPB.